Literature DB >> 29689304

Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma.

Clizia Chinello1, Martina Stella2, Isabella Piga2, Andrew James Smith2, Giorgio Bovo3, Marta Varallo4, Mariia Ivanova2, Vanna Denti2, Marco Grasso5, Angelica Grasso5, Marina Del Puppo2, Apostolos Zaravinos6, Fulvio Magni2.   

Abstract

Liquid biopsies, as blood and urine, could offer an invaluable, easily accessible source of biomarkers, and evidences for elucidating the pathological processes. Only few studies integrated the proteomes driven by more than one biofluid. Furthermore, it is not clear which biofluid better mirrors the alterations triggered by disease. Venous infiltrating RCC(Renal Cell Carcinoma) could represent an advantageous model for exploring this aspect. Herein, we investigate how blood and urine "proteomically" reflect the changes occurring during RCC infiltration into renal vein(RV) by label-free nLC-ESI-MS/MS. We found 574 and 58 differentially expressed proteins(DEPs) in response to vascular involvement. To the augment of vascular involvement, the abundance of only three proteins in urine(UROM,RALA,CNDP1) and two in plasma(APOA1,K2C1) diminished while increased for twenty-six urinary proteins. 80 proteins were found both in urine and plasma, among which twenty-eight were DEPs. A huge overlap between the two biofluids was highlighted, as expected, being urine the filtrate of blood. However, this consistency decreases when RV-occlusion occurs suggesting alternative protein releases, and a loss of kidney architecture. Moreover, several proteomic and functional signatures were biofluid-specific. In conclusion, the complementarity between the specimens allowed to achieve a deeper level of molecular complexity of the RCC venous infiltration. SIGNIFICANCE: Although plasma and urine are strongly interconnected, only few proteomic studies investigated the complementarity of these fluids as bio-sources of information. Moreover, none of them was focused to their analysis and comparison in the context of vascular infiltration of renal cancer. Herein, new insights were gained regarding the impact into urinary and plasma proteome of the changes triggered by the ccRCC invasion into vascular system and renal vein. Furthermore, the integration of the information driven by the two liquid biopsies permits to unravel biological processes otherwise lost.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Mass spectrometry; Plasma; Proteomics; Renal cell carcinoma; Renal vein invasion; Urine

Mesh:

Substances:

Year:  2018        PMID: 29689304     DOI: 10.1016/j.jprot.2018.04.029

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  7 in total

1.  Functional heterogeneity of lymphocytic patterns in primary melanoma dissected through single-cell multiplexing.

Authors:  Francesca Maria Bosisio; Asier Antoranz; Yannick van Herck; Maddalena Maria Bolognesi; Lukas Marcelis; Clizia Chinello; Jasper Wouters; Fulvio Magni; Leonidas Alexopoulos; Marguerite Stas; Veerle Boecxstaens; Oliver Bechter; Giorgio Cattoretti; Joost van den Oord
Journal:  Elife       Date:  2020-02-14       Impact factor: 8.140

2.  3D gelatin-chitosan hybrid hydrogels combined with human platelet lysate highly support human mesenchymal stem cell proliferation and osteogenic differentiation.

Authors:  Federica Re; Luciana Sartore; Vladimira Moulisova; Marco Cantini; Camillo Almici; Andrea Bianchetti; Clizia Chinello; Kamol Dey; Silvia Agnelli; Cristina Manferdini; Simona Bernardi; Nicola F Lopomo; Emilio Sardini; Elisa Borsani; Luigi F Rodella; Fabio Savoldi; Corrado Paganelli; Pierangelo Guizzi; Gina Lisignoli; Fulvio Magni; Manuel Salmeron-Sanchez; Domenico Russo
Journal:  J Tissue Eng       Date:  2019-05-02       Impact factor: 7.813

3.  A Blood Bank Standardized Production of Human Platelet Lysate for Mesenchymal Stromal Cell Expansion: Proteomic Characterization and Biological Effects.

Authors:  Andrea Bianchetti; Clizia Chinello; Michele Guindani; Simona Braga; Arabella Neva; Rosanna Verardi; Giovanna Piovani; Lisa Pagani; Gina Lisignoli; Fulvio Magni; Domenico Russo; Camillo Almici
Journal:  Front Cell Dev Biol       Date:  2021-05-14

4.  APOA1 mRNA and protein in kidney renal clear cell carcinoma correlate with the disease outcome.

Authors:  Wei Zeng; Guoguang Xiong; Li Hua; Yugang Hu; Xufeng Guo; Xiulan Peng
Journal:  Sci Rep       Date:  2022-07-20       Impact factor: 4.996

Review 5.  Proteomic approaches for characterizing renal cell carcinoma.

Authors:  David J Clark; Hui Zhang
Journal:  Clin Proteomics       Date:  2020-07-29       Impact factor: 3.988

6.  In-Depth Mapping of the Urinary N-Glycoproteome: Distinct Signatures of ccRCC-related Progression.

Authors:  Lucia Santorelli; Giulia Capitoli; Clizia Chinello; Isabella Piga; Francesca Clerici; Vanna Denti; Andrew Smith; Angelica Grasso; Francesca Raimondo; Marco Grasso; Fulvio Magni
Journal:  Cancers (Basel)       Date:  2020-01-18       Impact factor: 6.639

Review 7.  Liquid Biopsies in Renal Cell Carcinoma-Recent Advances and Promising New Technologies for the Early Detection of Metastatic Disease.

Authors:  Harini Lakshminarayanan; Dorothea Rutishauser; Peter Schraml; Holger Moch; Hella A Bolck
Journal:  Front Oncol       Date:  2020-10-28       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.